Clinical Research Directory
Browse clinical research sites, groups, and studies.
HPV-based Screening Among Women 23-29 Years of Age
Sponsor: Karolinska Institutet
Summary
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.
Official title: Evaluation of Organized Human Papilloma Virus (HPV) Screening of 23-29-year-old Women
Key Details
Gender
FEMALE
Age Range
23 Years - 29 Years
Study Type
INTERVENTIONAL
Enrollment
180000
Start Date
2020-11-16
Completion Date
2038-12-31
Last Updated
2025-03-19
Healthy Volunteers
No
Interventions
HPV testing
All women age 23-29 resident in the pilot counties will be invited to HPV screening as of the study start date. The same invitation as currently used for women aged 30 and upwards will be used. This information clearly states that it is possible to opt out of the program and that data from the screening program will be collected to regional and national quality registers who will systematically evaluate the quality of the care. At the screening station, the samples are collected identically regardless of primary screening test used - there is no change in the procedures used neither for the woman or for the midwives taking the sample. HPV testing will be performed using the same purchased, CE-marked and accredited HPV screening platforms as currently used for women aged 30 and upwards. The cytology is according to the liquid-based cytology method.
Locations (2)
Region of Skåne
Lund, Skåne County, Sweden
Region Stockholm
Stockholm, Sweden